Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://ncbi.nlm.nih.gov/pubmed/26620566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1949-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items